Aurelien Olichon

Dr. Aurelien Olichon

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2016 in eLife
Verified
Journal Article
Open access
SMSandrine Moutel
Sandrine Moutel
NBNicolas BERY
Nicolas BERY
VBVirginie Bernard
Virginie Bernard
LKLaura Keller
Laura Keller
ELEmilie Lemesre
Emilie Lemesre
FPFranck Perez
Franck Perez
In vitro selection of antibodies allows to obtain highly functional binders, rapidly and at lower cost. Here, we describe the first fully synthetic phage display library of humanized llama single domain antibody (NaLi-H1: Nanobody Library Humanized 1). Based on a humanized synthetic single domain antibody (hs2dAb) scaffold optimized for intracellular stability, the highly diverse library provides high affinity binders without animal immunization. NaLi-H1 was screened following several selection schemes against various targets (Fluorescent proteins, actin, tubulin, p53, HP1). Conformation antibodies against active RHO GTPase were also obtained. Selected hs2dAb were used in various immunoassays and were often found to be functional intrabodies, enabling tracking or inhibition of endogenous targets. Functionalization of intrabodies allowed specific protein knockdown in living cells. Finally, direct selection against the surface of tumor cells produced hs2dAb directed against tumor-specific antigens further highlighting the potential use of this library for therapeutic applications.

28 December 2018 in mAbs
Verified
Journal Article
Open access
MMManuel Maidorn
Manuel Maidorn
AOAurelien Olichon
Aurelien Olichon
SRSilvio O. Rizzoli
Silvio O. Rizzoli
FOFelipe Opazo
Felipe Opazo
Synaptic vesicle fusion (exocytosis) is a precisely regulated process that entails the formation of SNARE complexes between the vesicle protein synaptobrevin 2 (VAMP2) and the plasma membrane proteins Syntaxin 1 and SNAP-25. The sub-cellular localization of the latter two molecules remains unclear, although they have been the subject of many recent investigations. To address this, we generated two novel camelid single domain antibodies (nanobodies) specifically binding to SNAP-25 and Syntaxin 1A. These probes penetrated more easily into samples and detected their targets more efficiently than conventional antibodies in crowded regions. When investigated by super-resolution imaging, the nanobodies revealed substantial extra-synaptic populations for both SNAP-25 and Syntaxin 1A, which were poorly detected by antibodies. Moreover, extra-synaptic Syntaxin 1A molecules were recruited to synapses during stimulation, suggesting that these are physiologically-active molecules. We conclude that nanobodies are able to reveal qualitatively and quantitatively different organization patterns, when compared to conventional antibodies.

1 July 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
DJDenis Jullien
Denis Jullien
JVJulien Vignard
Julien Vignard
YFYoann Fedor
Yoann Fedor
NBNicolas BERY
Nicolas BERY
AOAurelien Olichon
Aurelien Olichon
Gladys MireyGladys Mirey
Gladys Mirey
Chromatin function is involved in many cellular processes, its visualization or modification being essential in many developmental or cellular studies. Here, we present the characterization of chromatibody, a chromatin-binding single-domain, and explore its use in living cells. This non-intercalating tool specifically binds the heterodimer of H2A–H2B histones and displays a versatile reactivity, specifically labeling chromatin from yeast to mammals. We show that this genetically encoded probe, when fused to fluorescent proteins, allows non-invasive real-time chromatin imaging. Chromatibody is a dynamic chromatin probe that can be modulated. Finally, chromatibody is an efficient tool to target an enzymatic activity to the nucleosome, such as the DNA damage-dependent H2A ubiquitylation, which can modify this epigenetic mark at the scale of the genome and result in DNA damage signaling and repair defects. Taken together, these results identify chromatibody as a universal non-invasive tool for either in vivo chromatin imaging or to manipulate the chromatin landscape.

1 November 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
NBNicolas BERY
Nicolas BERY
LKLaura Keller
Laura Keller
MSMarjorie Soulié
Marjorie Soulié
RGRémi Gence
Rémi Gence
AIAnne-Laure Iscache
Anne-Laure Iscache
AOAurelien Olichon
Aurelien Olichon


9 January 2020 in Haematologica
Verified
Journal Article
Open access
PDF file
CLChantal Lagresle-Peyrou
Chantal Lagresle-Peyrou
AOAurelien Olichon
Aurelien Olichon
HSHanem Sadek
Hanem Sadek
PRPhilippe Roche
Philippe Roche
CTClaudine Tardy
Claudine Tardy
MCMarina Cavazzana
Marina Cavazzana
Severe combined immunodeficiencies (SCIDs) constitute a heterogeneous group of life-threatening genetic disorders that typically present in the first year of life. They are defined by the absence of autologous T cells and the presence of an intrinsic or extrinsic defect in the B-cell compartment. In three newborns presenting with frequent infections and profound leukopenia, we identified a private, heterozygous mutation in the RAC2 gene (p.G12R). This mutation was de novo in the index case, who had been cured by hematopoietic stem cell transplantation but had transmitted the mutation to her sick daughter. Biochemical assays showed that the mutation was associated with a gain of function. The results of in vitro differentiation assays showed that RAC2 is essential for the survival and differentiation of hematopoietic stem/progenitor cells. Therefore, screening for RAC2 gain-of-function mutations should be considered in patients with a SCID phenotype and who lack a molecular diagnosis.